Tubize-Fin

Price Chart

Risk-Adjusted Performance

Also Listed On

Tubize-Fin (TUB) Price Performance

Tubize-Fin (TUB) trades on BR in EUR. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at EUR228.20, up 3.45% from the previous close.

Over the past year, TUB has traded between a low of EUR110.73 and a high of EUR247.50. The stock has gained 106.1% over this period. It is currently 7.8% below its 52-week high.

Tubize-Fin has a market capitalization of $10.16B, with a price-to-earnings ratio of 108.67 and a dividend yield of 0.49%.

About Tubize-Fin

Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affect the immune system or the central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.